基层医疗实践促进项目对慢性肾脏病管理的长期有效性:FROM-J整群随机研究的延长随访
本研究对FROM-J整群随机试验进行10年延长随访,评估基层医生慢性肾脏病管理促进项目的长期效果。结果显示干预组主要复合终点发生率有降低趋势(27.1% vs 22.1%,P=0.051),心血管疾病发生率显著降低(10.5% vs 6.4%,P=0.001),且在入组时G3a期患者中干预组eGFR下降速率显著更优。
要点
- 干预组主要复合终点发生率为22.1%,对照组为27.1%,差异未达统计学显著(P=0.051)。
- 干预组心血管疾病发生率6.4%,显著低于对照组的10.5%(P=0.001)。
- 入组时G3a期患者中,干预组eGFR年下降速率1.68±2.98,优于对照组的2.35±3.87 mL/min/1.73 m²(P=0.02)。
核心结论
- 针对基层医生的CKD实践促进项目可可靠地减少心血管疾病事件,并可能减少病例进展至终末期肾病。
研究设计与样本
- 本研究为FROM-J整群随机对照试验的延长10年随访,纳入原FROM-J研究中的患者。
- 原试验为期3.5年,设两组:A组不实施实践促进项目,B组实施实践促进项目。
主要发现
- 主要复合终点(心血管疾病、启动肾脏替代治疗、eGFR下降50%)发生率B组为22.1%,A组为27.1%,B组有降低趋势但未达统计学显著(P=0.051)。
- 心血管疾病发生率B组为6.4%,显著低于A组的10.5%(P=0.001)。
- 两组的死亡率与eGFR下降率整体相同;仅在入组时为G3a期的患者中,eGFR年下降速率B组为1.68±2.98 mL/min/1.73 m²,优于A组的2.35±3.87 mL/min/1.73 m²(P=0.02)。
- 基层医生与肾科医生之间的协作率B组高于A组。
临床怎么用
- 原文未据此给出推荐;原文结论为CKD实践促进项目可可靠地减少心血管疾病事件,并可能减少病例进展至终末期肾病。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Practice facilitation program by multidisciplinary care for primary care physicians (PCPs) is expected to improve chronic kidney disease (CKD) outcomes, but there is no clear evidence of its long-term effectiveness. We have previously performed a cluster-randomized controlled trial for 3.5 years (the Frontier of Renal Outcome Modifications in Japan (FROM-J) study) with two arms-group A without the program and group B with the program. We aimed to assess the long-term effectiveness of the practice facilitation program on CKD outcomes via an extended 10-year follow-up of the FROM-J study. METHODS: We enrolled patients who were in the FROM-J study. The primary composite endpoint comprised cardiovascular disease (CVD), renal replacement therapy initiation and a 50% decrease in the estimated glomerular filtration rate (eGFR). The secondary endpoints were survival rate, eGFR decline rate and collaboration rate between PCPs and nephrologists. RESULTS: The occurrence of the primary composite endpoint tended to be lower in group B (group A: 27.1% versus group B: 22.1%, P = 0.051). Furthermore, CVD incidence was remarkably lower in group B (group A: 10.5% versus group B: 6.4%, P = 0.001). Although both mortality and the rate of eGFR decline were identical between both groups, the eGFR decline rate was significantly better in group B than in group A only in patients with stage G3a at enrollment (group A: 2.35 ± 3.87 mL/min/1.73 m2/year versus group B: 1.68 ± 2.98 mL/min/1.73 m2/year, P = 0.02). The collaboration rate was higher in group B. CONCLUSIONS: The CKD practice facilitation program for PCPs reliably decreases CVD events and may reduce the progression of cases to end-stage kidney disease.
引用
- Imasawa T, Saito C, Kai H, et al. Long-term effectiveness of a primary care practice facilitation program for chronic kidney disease management: an extended follow-up of a cluster-randomized FROM-J study. Nephrol Dial Transplant. 2023. PMID: 35195257. doi:10.1093/ndt/gfac041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。